Year: 2022

BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention based on a novel multi-antigen vaccine approach First evaluated candidate BNT165b1 expresses certain parts of the circumsporozoite protein (CSP) BNT165 program will assess other vaccine targets to identify the multi-antigen vaccine candidate that will proceed into planned later-stage clinical developmentMAINZ, Germany, December 23, 2022 – BioNTech SE (Nasdaq: BNTX, “BioNTech”, “the Company”) today announced the initiation of a first-in-human Phase 1 study with BNT165b1, the first candidate from the Company’s BNT165 program, to develop a multi-antigen malaria vaccine candidate. BioNTech will initially evaluate a set of mRNA-encoded antigens of the malaria-causing parasite Plasmodium falciparum (P. falciparum) to help select the multi-antigen vaccine...

AS Baltika publishes the consolidated financial results as follows:28.02.2023  Unaudited interim report for the IV quarter28.04.2023  Audited annual report for 202231.05.2023  Unaudited interim report for the I quarter31.08.2023  Unaudited interim report for the II quarter30.11.2023  Unaudited interim report for the III quarterThe financial results will be announced in Estonian and English on the dates listed above at 8:00 a.m. local Eastern European Time (EET). The 2022 annual general meeting of shareholders will be held in the second quarter of 2023, the exact time and location will be specified later. Margus OleskMember of the Management Board, CFOmargus.olesk@baltikagroup.com

Talenom Plc Press release 23 December 2022 at 10:00 EET Talenom expands to Italy by acquiring the business of Studio Gavazzi, an Italian accounting company Talenom Plc has agreed on to acquire the accounting business of Studio Gavazzi located in Milan, Italy. With the acquisition Talenom will start operating on the Italian market. The acquired business will be transferred to Talenom on 1 January 2023. According to our estimate, the size of the Italian accounting service market is around EUR 12 billion and the number of accounting firms in Italy is over 64,000. There are around six million companies in Italy, of which over 99 % are SMEs. The acquisition opens the possibility for Talenom to expand its business to one of the largest European markets and participate in the digitalization of the Italian accounting industry. The net sales transferred...

Aktia Bank PlcStock Exchange Release23 December 2022 at 10.00 a.m. Aktia Bank Plc – Managers’ transactions – Perttu Purhonen____________________________________________ Person subject to the notification requirementName: Purhonen, PerttuPosition: Other senior managerIssuer: Aktia Bank plcLEI: 743700GC62JLHFBUND16 Notification type: INITIAL NOTIFICATIONReference number: 743700GC62JLHFBUND16_20221222090546_121____________________________________________ Transaction date: 2022-12-21Venue not applicableInstrument type: SHAREISIN: FI4000058870Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 136 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 136 Volume weighted average price: 0.00 EUR Aktia Bank Plc Further information:Ari Syrjäläinen, General Counsel, tel. +358 10 247 6350 Distribution:Nasdaq...

INVL Baltic Sea Growth Fund, the leading private equity investment fund in the Baltic region, has completed the acquisition of the most modern medical treatment centres in Birštonas, Nemunas as well as the largest rehabilitation and post-acute care treatment centres in the Baltics, Eglės Sanatorija. The transactions were closed following regulatory approval from the Lithuanian Competition Council. Nerijus Drobavičius, Partner at INVL Baltic Sea Growth Fund, commented: “We are continuing to invest in this high performing sector and look forward to further strengthening leading position in the Baltic States, created by the shareholders, managers and employees of the company. The healthcare sector in Lithuania and the entire Baltic region, as well as in other European Union countries, has high potential for growth as society continues...

Japanese regulatory authority granted marketing authorization to Basilea’s license partner, Asahi Kasei Pharma Intravenous and oral use of Cresemba approved for the treatment of adult patients with aspergillosis, mucormycosis, and cryptococcosisBasel/Allschwil, Switzerland, December 23, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that its license partner Asahi Kasei Pharma (“AKP”), has received the marketing authorization from the Ministry of Health, Labour and Welfare (MHLW) in Japan for Cresemba® (isavuconazole) for the treatment of adult patients with aspergillosis, mucormycosis, and cryptococcosis. Aspergillosis and cryptococcosis were recently listed by the World Health Organization...

On 21 December 2022, Harju Elekter Group’s Swedish subsidiary Harju Elekter AB signed an agreement with Gävle Energi AB, for the upgrade of the distribution substation in Gävle with accompanying rebuilding and civil works of the project by February 2024. The total volume of the agreement is 1.6 million euros. This is yet another larger substation project for Harju Elekter AB in Sweden. Once completed, the station will contribute to meeting the need for electrical power, both for industrial and residential users. Gävle Energi AB is an energy company in the Gävle region, 170 km north of Stockholm, offering energy services, district heating and cooling. Harju Elekter is an international industrial group with extensive experience in providing future proof solutions for electrical power distribution. We engineer, manufacture, and install electrification...

The Group revenue during the first quarter of FY2023 stood at 28 435 thousand EUR, while during the same period of FY2022 revenue was 26 847 thousand EUR. Net losses of the Group during the first three months were 579 thousand EUR, at the same period last year net losses were 1 903 thousand EUR. EBITDA was 992 thousand EUR, while a year ago it was negative and stood at -251 thousand EUR.Additional information:General managerJonas KrutinisPhone No: +370 5 2525700AttachmentsVILNIAUS BALDAI AB non audited results for the three months of FY 2023Responsible persons confirmation

As a result of a regular review of the structure of the AS Merko Ehitus group, it was decided to terminate the subsidiaries OY Merko Finland (Finland, construction and development) and PS “Merko Merks” (Latvia, joint offers for construction), 100% of which belong to the group, due to the lack of activity in those companies. At the same time, it was decided to establish construction company Merko Būve in Latvia, a subsidiary owned 100% by the group, in order to strengthen specialisation and brand unification. The terminations and foundations set out in the notice have negligible effect on the activities of as Merko Ehitus, nor are these transactions regarded as transactions with related parties within the meaning of the section “Requirements for Issuers” of the rules of the stock exchange organised by NASDAQ OMX Tallinn AS. Members of the...

CALGARY, Alberta, Dec. 22, 2022 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX: SFD; OTCQB: NSFDF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to offer a multi-tranche private placement (the “Private Placement”) under which the subscribers will be able to purchase up to 11,900,770 common shares of the Company at a price of $0.195 per share for total gross proceeds of approximately $2,320,650. As of December 22, 2022, the amount of $1,789,765 or 9,178,282 common shares have been subscribed for by participants in the Private Placement. The Company intends to complete the remaining $530,885 of the Private Placement by January 27, 2023. Common shares issued as a result of the Private Placement will be subject...